Welcome to our dedicated page for Aptargroup SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AptarGroup, Inc.'s SEC filings document operating results, governance matters and capital-structure activity for a NYSE-listed maker of drug delivery and consumer-product dispensing technologies. Form 8-K reports furnish quarterly and annual results, segment commentary for Pharma, Beauty and Closures, shareholder returns and material events tied to the company's operations.
The filing record also includes proxy materials and annual meeting vote results covering director elections, advisory compensation matters and stockholder voting items. Capital disclosures include common stock registered under the Exchange Act, shelf-registration activity and completed debt financing, including the 4.750% Senior Notes due 2031 issued under an indenture.
AptarGroup, Inc. (ATR) furnished an 8-K announcing that it released certain information related to its results of operations for the quarter ended September 30, 2025. The company provided a press release as Exhibit 99.1.
The company stated the furnished information in Item 2.02 and Exhibit 99.1 is not deemed “filed” under Section 18 of the Exchange Act and is not incorporated into other filings unless specifically referenced. AptarGroup’s common stock trades on the NYSE under the symbol ATR.
AptarGroup (ATR) insider sale by Segment President Touya Gael. The Form 4 reports that on 09/11/2025 Mr. Gael sold a total of 2,500 shares of AptarGroup common stock in two sets of transactions: 2,110 shares at a weighted-average price of $136.1325 and 390 shares at a weighted-average price of $136.0467. Following those reported sales, the filing shows beneficial ownership of 31,853 shares after the first sale and 31,463 shares after the second sale. The filing was signed by an attorney-in-fact on 09/12/2025 and includes explanations that the reported prices are weighted averages across multiple trades.
AptarGroup, Inc. (ATR) filed a Form 144 notifying the proposed sale of 2,500 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $340,297.75 and an approximate sale date of 09/11/2025. The filing reports total outstanding shares of 65,880,522, which gives context to the size of the proposed sale relative to the company's share count.
The securities listed were acquired in 2021 through restricted stock vesting under a registered plan: 603 shares on 03/25/2021, 1,126 shares on 02/28/2021 and 771 shares on 03/23/2021, each noted as payment for services rendered. The filer indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Insider sale reported: Shiela Vinczeller, Chief Human Resources Officer of AptarGroup, Inc. (ATR), reported selling 1,167 shares of AptarGroup common stock on 09/05/2025 at a weighted average price of $137.9661 per share. Following the sale, the filing shows she beneficially owns 25,134 shares, held directly.
The Form 4 was signed by an attorney-in-fact on 09/08/2025 and includes an explanation that the reported price is a weighted average for multiple transactions executed between $137.85 and $138.09. The filing is a routine Section 16 disclosure of a non-derivative disposition by an officer.
AptarGroup, Inc. (ATR) filed a Form 144 reporting a proposed sale of 1,167 common shares. The sale is to be handled by Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $161,006.44 and an approximate sale date of 09/05/2025. The shares were acquired on 05/02/2025 through restricted stock vesting under a registered plan and were issued by the issuer as payment for services rendered on 05/02/2025. The filer reports no securities sold in the past three months. The filing includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.